Rein Therapeutics RNTX
NASDAQ RNTX
$0.80 -0.05 (-5.88%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Non Operating Investment Income (2020)

Updated

Rein Therapeutics (RNTX) recorded Non Operating Investment Income of $20,000 in Q4 2020.

Analysis

Rein Therapeutics (RNTX) Non Operating Investment Income (2020) Analysis & Trends

For FY2020, Rein Therapeutics reported Non Operating Investment Income of $86,000.

  • Across earlier years, Non Operating Investment Income came in at -$5,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Rein Therapeutics 53.67 Mn 53.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 20,000.00
Mar 31, 2020 66,000.00
API Access

Rein Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=RNTX&period=max&api_key=YOUR_API_KEY